The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 28, 2025
Filed:
Feb. 21, 2023
Applicants:
Universität Basel, Basel, CH;
Paul Scherrer Institute, Villigen-PSI, CH;
Inventors:
Cristina Müller, Nussbaumen, CH;
Roger Schibli, Baden, CH;
Nicholas Philip Van Der Meulen, Schinznach-Dorf, CH;
Francesca Borgna, Windisch, CH;
Damian Wild, Basel, CH;
Melpomeni Fani, Basel, CH;
Assignees:
Universität Basel, Basel, CH;
Paul Scherrer Institute, Villigen-PSI, CH;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/08 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61K 51/12 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 51/083 (2013.01); A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 47/12 (2013.01); A61K 47/22 (2013.01); A61K 51/088 (2013.01); A61K 51/121 (2013.01); A61P 35/00 (2018.01);
Abstract
A radiopeptide is provided which comprises (a) a radionuclide, wherein the radionuclide is terbium-161, (b) a chelator coordinating terbium-161, and (c) a peptide or peptide analogue, which is a somatostatin receptor (SSTR) antagonist. The radiopeptide is suitable for use in the treatment of tumor diseases.